These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6662144)

  • 21. Triglyceride levels after Intralipid infusion in children with cystic fibrosis.
    Allué X; Sanjurjo P
    Pediatrics; 1978 Jun; 61(6):924-5. PubMed ID: 97619
    [No Abstract]   [Full Text] [Related]  

  • 22. Pancreatic insufficiency in cystic fibrosis: result of defect in ontogenesis of the exocrine pancreas.
    Lebenthal E
    J Pediatr Gastroenterol Nutr; 1984; 3 Suppl 1():S51-4. PubMed ID: 6502394
    [No Abstract]   [Full Text] [Related]  

  • 23. Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture.
    Caramia G; Cocchi M; Gagliardini R; Malavolta M; Mozzon M; Frega NG
    Pediatr Med Chir; 2003; 25(1):42-9. PubMed ID: 12920976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current research trends in cystic fibrosis (mucoviscidosis).
    Périni JM; Scharfman A; Lafitte JJ; Marianne T; Lamblin G; Roussel P
    Bull Eur Physiopathol Respir; 1985; 21(6):569-82. PubMed ID: 3907739
    [No Abstract]   [Full Text] [Related]  

  • 25. [Concentration of plasma beta-carotene in cystic fibrosis children with pancreatic insufficiency].
    Laskowska-Klita T; Chełchowska M
    Med Wieku Rozwoj; 2002; 6(3):267-72. PubMed ID: 12637781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency.
    Durie PR; Forstner GG; Gaskin KJ; Moore DJ; Cleghorn GJ; Wong SS; Corey ML
    Pediatr Res; 1986 Mar; 20(3):209-13. PubMed ID: 3703609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between essential fatty acid levels, pulmonary function and fat absorption in pre-adolescent cystic fibrosis children with good clinical scores.
    Thompson GN
    Eur J Pediatr; 1989 Jan; 148(4):327-9. PubMed ID: 2707278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic-sufficient patients with cystic fibrosis.
    Couper RT; Corey M; Durie PR; Forstner GG; Moore DJ
    J Pediatr; 1995 Sep; 127(3):408-13. PubMed ID: 7658271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy.
    Aldámiz-Echevarría L; Prieto JA; Andrade F; Elorz J; Sojo A; Lage S; Sanjurjo P; Vázquez C; Rodríguez-Soriano J
    Pediatr Res; 2009 Nov; 66(5):585-9. PubMed ID: 19851226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal associations among energy intake, plasma linoleic acid, and growth improvement in response to treatment initiation after diagnosis of cystic fibrosis.
    Shoff SM; Ahn HY; Davis L; Lai H;
    Pediatrics; 2006 Feb; 117(2):391-400. PubMed ID: 16452358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis.
    Coste TC; Deumer G; Reychler G; Lebecque P; Wallemacq P; Leal T
    Clin Chem; 2008 Feb; 54(2):388-95. PubMed ID: 18089657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary intake and nutritional status of micronutrients in adults with cystic fibrosis in relation to current recommendations.
    Li L; Somerset S
    Clin Nutr; 2016 Aug; 35(4):775-82. PubMed ID: 26159903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoreactive pancreatic Reg protein in sera from cystic fibrosis patients with and without pancreatic insufficiency.
    Carrère J; Guy-Crotte O; Gaia E; Figarella C
    Gut; 1999 Apr; 44(4):545-51. PubMed ID: 10075963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipids in cystic fibrosis.
    Rosenlund ML; Walsh EP; Scott DA; Kritchevsky D
    Curr Concepts Nutr; 1979; 8():219-27. PubMed ID: 393469
    [No Abstract]   [Full Text] [Related]  

  • 35. Malnutrition-associated rash of cystic fibrosis.
    Darmstadt GL; McGuire J; Ziboh VA
    Pediatr Dermatol; 2000; 17(5):337-47. PubMed ID: 11085658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Essential-fatty-acid metabolism in cystic fibrosis.
    Press M
    Lancet; 1975 Nov; 2(7940):871-2. PubMed ID: 53355
    [No Abstract]   [Full Text] [Related]  

  • 37. Letter: Defective essential-fatty-acid metabolism in cystic fibrosis.
    Thompson G
    Lancet; 1975 Oct; 2(7938):769. PubMed ID: 52793
    [No Abstract]   [Full Text] [Related]  

  • 38. Calcium-ATPase activity in cystic fibrosis erythrocyte membranes: decreased activity in patients with pancreatic insufficiency.
    Dearborn DG; Wityk RJ; Johnson LR; Poncz L; Stern RC
    Pediatr Res; 1984 Sep; 18(9):890-5. PubMed ID: 6091022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter: Essential fatty acids in cystic fibrosis.
    Robinson PG
    Lancet; 1975 Nov; 2(7941):919. PubMed ID: 53393
    [No Abstract]   [Full Text] [Related]  

  • 40. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis.
    Strandvik B; Gronowitz E; Enlund F; Martinsson T; Wahlström J
    J Pediatr; 2001 Nov; 139(5):650-5. PubMed ID: 11713441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.